Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article discusses androgenetic alopecia, including its prevalence, different patterns in men and women, and variations among races, without providing new clinical findings.

This paper provides an overview of modern hair transplantation techniques and discusses the importance of patient selection and medication use for male pattern hair loss, but it reports no new results.

CRT is more effective than oral minoxidil alone for treating hair loss.

In this study, significant upregulation of the genes SFRP2 and PTGDS was found in bald hair follicles of female pattern hair loss patients compared to non-bald follicles, suggesting these genes may be biomarkers and play a role in hair loss for this condition.

This correspondence reports that some men with androgenetic alopecia can exhibit hair thinning patterns more typical of females, with variations observed between Australian and Korean populations.

This study established and validated a visual scale to assess hair shedding in women with thick hair, finding it effective in distinguishing greater hair loss among women with female pattern hair loss compared to those without.

This review discusses female pattern hair loss, its psychological impact, and available treatments but provides no new clinical findings; the authors emphasize early intervention for better outcomes.

This study observed that white hair can create an optical illusion of increased scalp visibility, potentially misleading clinical evaluations of hair loss and complicating hair transplantation planning, and identified five core dyeing strategies to address this phenomenon.

The authors discuss that hair loss affecting the occipital scalp is understudied and may be caused by factors like movement irritation and clothing occlusion; this lack of data can lead to missed diagnoses and inadequate treatment.

This study demonstrates that inhibiting SFRP1 with the antagonist WAY-316606 enhances hair growth in human scalp hair follicles ex vivo by facilitating Wnt signalling.

This review discusses male androgenetic alopecia treatments, noting that topical minoxidil and oral finasteride are FDA-approved and require continuous use to maintain hair retention effects, but reports no new clinical results.

This review details historical advancements in understanding and treating superficial fungal infections, with notable milestones in identifying causative agents and developing effective treatments, but it reports no new findings.

This review addresses treatment approaches for female pattern hair loss, highlighting that combining different therapies may be more effective than single treatments, but no new results are reported.

In this study, a modified Sinclair scale was presented for evaluating hair loss severity in men with female pattern hair loss, outlining stages from normal hair density to severe hair loss while preserving the anterior hairline. Reliability data for using this scale was also included.

This review offers evidence-based recommendations for diagnosing and treating female pattern hair loss, emphasizing clinical assessment and starting treatment with minoxidil, while noting that measurement of certain hormones and vitamins is optional.

This study found that finasteride (1 mg) significantly increased hair growth in all scalp regions affected by male pattern hair loss over 24 months in men aged 18 to 60, with more pronounced effects in younger men.

This article reviews current knowledge on the causes, diagnosis, and medical treatments for androgenetic alopecia, particularly in men, and reports no new findings.

Low testosterone levels may contribute to female pattern hair loss in men.

This article reviews the historical developments in understanding and treating male pattern hair loss, emphasizing the role of dihydrotestosterone and 5α-reductase inhibitors, but reports no new clinical findings.

This study reported that finasteride 1 mg/day significantly increased hair growth and slowed hair loss in men with frontal scalp hair thinning over one year, and these benefits continued or improved in the second year.

This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

This article reviews various causes and investigative techniques for different forms of alopecia and reports no new findings.

This study found that trichoscopy using anisotrichosis criteria was 75% sensitive and 61.54% specific in diagnosing early female pattern hair loss in women without visible hair thinning.

This study found that thermal hair straightening in Asian women was associated with various signs of scalp and hair damage, including CCCA-like hair loss.

Finasteride improves hair growth and satisfaction in men with male pattern baldness but may cause sexual side effects.

This study found that when choosing between hair transplant and scalp micropigmentation for female pattern hair loss, scalp micropigmentation is preferred if hair density is at least 104.6 hairs/cm².

Finasteride's effectiveness on the frontal hair loss area is not well-studied or confirmed.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

The study found that prolactin expressed in human scalp hair follicles acts as an autocrine modulator, inhibiting hair growth and promoting hair follicle regression, which may contribute to hair loss in hyper-prolactinemia patients.